FDA
-
-
-
-
-
-
-
Dexcom to present diabetes study results and launch updated glucose app
-
-
-
-
-
-
-
Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes
-
-
-
-
-
-
-
Dexcom Launches Its First Open Call to Uncover the Next Diabetes Advocates Ahead of World Diabetes Day
-
-
-
-
-
-
-
Dexcom Reports First Quarter 2025 Financial Results and Announces $750 Million Share Repurchase Program
-
-
-
-
-
-
-
Dexcom G7 15 Day Receives FDA Clearance: the Longest Lasting Wearable and Most Accurate CGM System
-
-
-
-
-
-
-
Is Trump 2.0 good or bad for healthcare stocks?
-
-
-
-
-
-
-
Dexcom Reports First Quarter 2024 Financial Results
-
326,431 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

